[go: up one dir, main page]

PT2114921E - Derivado de oxindol substituído e sua utilização como ligante do recetor de vasopressina - Google Patents

Derivado de oxindol substituído e sua utilização como ligante do recetor de vasopressina

Info

Publication number
PT2114921E
PT2114921E PT78582129T PT07858212T PT2114921E PT 2114921 E PT2114921 E PT 2114921E PT 78582129 T PT78582129 T PT 78582129T PT 07858212 T PT07858212 T PT 07858212T PT 2114921 E PT2114921 E PT 2114921E
Authority
PT
Portugal
Prior art keywords
receptor ligand
vasopressin receptor
oxindole derivative
substituted oxindole
substituted
Prior art date
Application number
PT78582129T
Other languages
English (en)
Inventor
Astrid Netz
Thorsten Oost
Herve Geneste
Wilfried Martin Braje
Wolfgang Wernet
Liliane Unger
Wilfried Hornberger
Wilfried Lubisch
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of PT2114921E publication Critical patent/PT2114921E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT78582129T 2006-12-30 2007-12-28 Derivado de oxindol substituído e sua utilização como ligante do recetor de vasopressina PT2114921E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006062508 2006-12-30

Publications (1)

Publication Number Publication Date
PT2114921E true PT2114921E (pt) 2013-03-26

Family

ID=39140670

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78582129T PT2114921E (pt) 2006-12-30 2007-12-28 Derivado de oxindol substituído e sua utilização como ligante do recetor de vasopressina

Country Status (9)

Country Link
EP (1) EP2114921B1 (pt)
CY (1) CY1114543T1 (pt)
DK (1) DK2114921T3 (pt)
ES (1) ES2401908T3 (pt)
PL (1) PL2114921T3 (pt)
PT (1) PT2114921E (pt)
RS (1) RS52700B (pt)
SI (1) SI2114921T1 (pt)
WO (1) WO2008080970A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US20080167286A1 (en) 2006-12-12 2008-07-10 Abbott Laboratories Pharmaceutical compositions and their methods of use
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
UY30846A1 (es) 2006-12-30 2008-07-31 Abbott Gmbh & Amp Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
WO2009071691A2 (de) * 2007-12-07 2009-06-11 Abbott Gmbh & Co. Kg Oxindol-derivate und ihre verwendung als medikament
WO2010009775A1 (de) * 2007-12-07 2010-01-28 Abbott Gmbh & Co. Kg Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
ES2455197T3 (es) 2007-12-07 2014-04-14 Abbvie Deutschland Gmbh & Co Kg Derivados de oxindol 5,6-disustituidos y el uso de los mismos para la preparación de un medicamento para el tratamiento de enfermedades dependientes de vasopresina
CA2707667C (en) * 2007-12-07 2016-02-23 Abbott Gmbh & Co. Kg Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
BRPI0820668A2 (pt) 2007-12-07 2017-08-22 Abbott Gmbh & Co Kg Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina
US9040568B2 (en) 2009-05-29 2015-05-26 Abbvie Inc. Pharmaceutical compositions for the treatment of pain
WO2010142739A1 (en) * 2009-06-10 2010-12-16 Abbott Gmbh & Co. Kg Use of substituted oxindole derivatives for the treatment and prophylaxis of pain
TWI527807B (zh) 2010-12-21 2016-04-01 拜耳智慧財產有限公司 N-磺醯基取代的吲哚酮之製法
CN105339366A (zh) 2013-03-14 2016-02-17 艾伯维德国有限责任两合公司 带有取代的氧杂环丁烷的2-吲哚酮衍生物及其治疗血管加压素相关疾病的用途
US9273036B2 (en) 2013-03-14 2016-03-01 AbbVie Deutschland GmbH & Co. KG Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases
US9840495B2 (en) 2013-12-20 2017-12-12 AbbVie Deutschland GmbH & Co. KG Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
US9862704B2 (en) 2013-12-20 2018-01-09 AbbVie Deutschland GmbH & Co. KG Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases
WO2015173392A1 (en) 2014-05-15 2015-11-19 AbbVie Deutschland GmbH & Co. KG Oxindole compounds carrying a co-bound spiro substituent and use thereof for treating vasopressin-related diseases
AU2016348493B2 (en) 2015-11-06 2021-02-25 F. Hoffmann-La Roche Ag Indolin-2-one derivatives
JP6839184B2 (ja) 2015-11-06 2021-03-03 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft インドリン−2−オン誘導体
WO2017076931A1 (en) 2015-11-06 2017-05-11 F. Hoffmann-La Roche Ag Indolin-2-one derivatives for use in the treatment of cns and related disorders
CN108137555B (zh) 2015-11-06 2021-02-19 豪夫迈·罗氏有限公司 可用于治疗cns疾病的二氢吲哚-2-酮衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070718A1 (en) * 2003-09-30 2005-03-31 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
DE102004033834A1 (de) * 2004-07-13 2006-02-02 Abbott Gmbh & Co. Kg Substituierte Oxindol-Derivate und diese enthaltende Arzneimittel
EP1861392A2 (de) * 2005-03-24 2007-12-05 Abbott GmbH & Co. KG Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
DE102005014904A1 (de) * 2005-03-26 2007-02-01 Abbott Gmbh & Co. Kg Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung

Also Published As

Publication number Publication date
CY1114543T1 (el) 2016-10-05
RS52700B (sr) 2013-08-30
WO2008080970A1 (en) 2008-07-10
EP2114921B1 (en) 2012-12-26
SI2114921T1 (sl) 2013-05-31
EP2114921A1 (en) 2009-11-11
HK1132741A1 (en) 2010-03-05
DK2114921T3 (da) 2013-03-25
PL2114921T3 (pl) 2013-05-31
ES2401908T3 (es) 2013-04-25

Similar Documents

Publication Publication Date Title
PL2114921T3 (pl) Podstawiona pochodna oksindolu i jej zastosowanie jako liganda receptora wazopresyny
ZA200904363B (en) Substituted oxindole derivatives and their use as vasopressin receptor ligands
EP2049520A4 (en) indole compounds
ZA200902585B (en) Indole compound
IL188039A0 (en) Oxindole derivatives
PL2017278T3 (pl) Pochodne dihydropirazolopirymidynonu
EP2009005A4 (en) AZOLECARBOXAMIDE DERIVATIVE
IL194391A0 (en) 5-amido-2-carboxamide indoles
IL180020A0 (en) Encryption -and decryption-enabled interfaces
EP1955697A4 (en) 2-AMINOBENZAMIDE DERIVATIVE
IL199430A0 (en) Crth2 antagonists
IL192270A0 (en) Substituted oxadiazole derivatives and their use as opioid receptor ligands
EP2131656A4 (en) phthalazine
ZA200905265B (en) Indole derivatives
ZA200904479B (en) Nitroderivatives as angiotensin II receptor antagonists
ZA200900843B (en) Indole compounds
IL198633A0 (en) Indoles
ZA200802339B (en) Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
GB201000798D0 (en) Poly-TLR antagonists
PL1918639T3 (pl) Podzespół palnika
EP1975162A4 (en) oxazolone derivatives
EP2130829A4 (en) NEW HYDROXYINDOLE DERIVATIVE
GB2438967B (en) Hopper unit
GB0603404D0 (en) Materials screen
GB0621406D0 (en) Kirby